Skip to main content
PMC home page
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2007 Sep;68(5):292–302. doi: 10.1016/j.curtheres.2007.10.004

The Effectiveness of Intramuscular Dexmedetomidine on Hemodynamic Responses During Tracheal Intubation and Anesthesia Induction of Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled Study

Kudret Dogru 1,a, Tugba Arik 1, Karamehmet Yildiz 1, Cihangir Bicer 1, Halit Madenoglu 1, Adem Boyaci 1
PMCID: PMC3969968  PMID: 24692761

Abstract

Background: Hypertensive patients are at risk for increased hemodynamic response to tracheal intubation. Sympatholytic drugs administered during the preinduction period may prevent adverse events.

Objective: We assessed the effectiveness of a single preinduction IM bolus dose of dexmedetomidine (DMED) 2.5 μg/kg in attenuating hemodynamic responses to tracheal intubation and rapid-sequence anesthesia induction in hypertensive patients treated with angiotensin-converting enzyme inhibitors.

Methods: Adult patients (American Society of Anesthesiologists classification II and III) with essential hypertension, scheduled for elective abdominal or gynecologic surgery, were enrolled in this randomized, double-blind, placebo-controlled study. Patients were assigned to i of 2 groups: the DMED group received IM DMED 2.5 μg/kg and the placebo group received IM saline 0.9% 45 to 60 minutes before induction of anesthesia. General anesthesia was induced with thiopental, fentanyl, and vecuronium and maintained with a sevoflurane-nitrous oxide-oxygen mixture. Hemodynamic values were recorded before (baseline) and after anesthesia induction, before endotracheal intubation, and 1, 3, and 5 minutes after intubation. The patients were monitored for hypotension (systolic arterial pressure [SAP] decreased ≥25% from baseline or to <90 mm Hg) or bradycardia (heart rate [HR] decreased ≥25% from baseline or to <50 beats/min).

Results: Nine hundred sixty patients were assessed for enrollment during a 6-month period. Sixty patients (49 women, 11 men; mean [SD] age, 59.16 [8.39] years) were eligible for the study. There were no significant differences in baseline hemodynamic values between the groups. SAP and diastolic arterial pressure (DAP) before anesthesia induction, 1 and 3 minutes after intubation, and DAP 1 minute after intubation were significantly lower in the DMED group than in the placebo group (all, P < 0.05). There were no significant between-group differences in SAP or DAP 5 minutes after intubation. HR before anesthesia induction, before intubation, and 1, 3, and 5 minutes after intubation were lower in the DMED group than in the control group (all, P < 0.05). In the DMED group, SAP after intubation, DAP before intubation, 3 and 5 minutes after intubation, HR before induction, before intubation, and 3 and 5 minutes after intubation were significantly decreased compared with baseline values (all, P < 0.05). In the control group, SAP at all times, DAP before intubation, 1, 3, and 5 minutes after intubation, HR before intubation, and 3 and 5 minutes after intubation were significantly decreased compared with baseline values (all, P < 0.05). Hypotension and bradycardia were observed together in 3 patients, and hypotension alone was observed in 1 patient 3 minutes after intubation in the DMED group; hypotension was observed in 1 patient at 3 minutes after intubation in the control group.

Conclusion: The results of this study suggest that IM DMED 2.5 μg/kg administered 45 to 60 minutes before anesthesia induction attenuated, but did not completely prevent, hemodynamic responses to tracheal intubation in these patients with essential hypertension.

Keywords: intramuscular, α2-adrenoceptor agonists, dexmedetomidine, tracheal intubation, heart rate, hypertension

Full Text

The Full Text of this article is available as a PDF (538.4 KB).

References

  • 1.Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology. 1991;74:581–605. [PubMed] [Google Scholar]
  • 2.Motsch J. Management of the cardiac risk patient. Baillieres BestPract Clin Anaesthesiol. 2000;14:369–380. [Google Scholar]
  • 3.Sohngen W, Winbury MM, Kitzen JM. The mechanism for the clonidineinduced coronary artery dilatation in the canine heart. J Cardiovasc Pharmacol. 1988;12:689–700. doi: 10.1097/00005344-198812000-00011. [DOI] [PubMed] [Google Scholar]
  • 4.Flacke JW. Alpha 2-adrenergic agonists in cardiovascular anesthesia. J Cardiothorac Vasc Anesth. 1992;6:344–359. doi: 10.1016/1053-0770(92)90156-2. [DOI] [PubMed] [Google Scholar]
  • 5.Tonner PH, Scholz J. Pre-anaesthetic administration of alpha2-adrenoceptor agonists. Baillieres Best Pract Clin Anaesthesiol. 2000;14:305–320. [Google Scholar]
  • 6.Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134–1142. doi: 10.1097/00000542-199212000-00014. [DOI] [PubMed] [Google Scholar]
  • 7.Scheinin H, Jaakola ML, Sjovall S. Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology. 1993;78:1065–1075. doi: 10.1097/00000542-199306000-00008. [DOI] [PubMed] [Google Scholar]
  • 8.Aho M, Scheinin M, Lehtinen AM. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg. 1992;75:932–939. [PubMed] [Google Scholar]
  • 9.World Medical Association Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects [WMA Web site]. Ferney-Voltaire, France: WMA; 1989.; September 15, 2007. http://www.wma.net Accessed.
  • 10.European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Geneva, Switzerland; WHO: 2002.; September 15, 2007. http://www.emea.eu.int Accessed.
  • 11.Keats AS. The ASA classification of physical status—a recapitulation. Anesthesiology. 1978;49:233–236. doi: 10.1097/00000542-197810000-00001. [DOI] [PubMed] [Google Scholar]
  • 12.Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New Joint National Committee guidelines. Arch Intern Med. 2004;164:2126–2134. doi: 10.1001/archinte.164.19.2126. [DOI] [PubMed] [Google Scholar]
  • 13.Singh M. Stress response and anesthesia: Altering perioperative management. Indian J Anaesth. 2003;47:427–434. [Google Scholar]
  • 14.Udelsman R, Norton JA, Jelnich SE. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab. 1987;64:986–994. doi: 10.1210/jcem-64-5-986. [DOI] [PubMed] [Google Scholar]
  • 15.Ensinger H, Weichel T, Lindner KH. Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers. Crit Care Med. 1993;21:1502–1508. doi: 10.1097/00003246-199310000-00018. [DOI] [PubMed] [Google Scholar]
  • 16.Roizen MF. Should we all have sympathectomy at birth? Or at least preoperatively? Anesthesiology. 1988;68:482–488. [PubMed] [Google Scholar]
  • 17.Kulka PJ, Tryba M, Zenz M. Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesth Analg. 1995;80:263–268. doi: 10.1097/00000539-199502000-00011. [DOI] [PubMed] [Google Scholar]
  • 18.Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–1133. doi: 10.1097/00000542-199212000-00013. [DOI] [PubMed] [Google Scholar]
  • 19.Erkola O, Korttila K, Aho M. Comparison of intramuscular dexmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesth Analg. 1994;79:646–653. doi: 10.1213/00000539-199410000-00006. [DOI] [PubMed] [Google Scholar]
  • 20.Levanen J, Makela ML, Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology. 1995;82:1117–1125. doi: 10.1097/00000542-199505000-00005. [DOI] [PubMed] [Google Scholar]
  • 21.Talke P, Chen R, Thomas B. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834–839. doi: 10.1097/00000539-200004000-00011. [DOI] [PubMed] [Google Scholar]
  • 22.Jorden VS, Tung A. Dexmedetomidine: Clinical update. Semin Anesth Periop Med Pain. 2002;21:265–274. [Google Scholar]
  • 23.Tanaka M, Nishikawa T. Oral clonidine premedication attenuates the hypertensive response to ketamine. Br J Anaesth. 1994;73:758–762. doi: 10.1093/bja/73.6.758. [DOI] [PubMed] [Google Scholar]
  • 24.Handa F, Tanaka M, Nishikawa T, Toyooka H. Effects of oral clonidine premedication on side efects of intravenous ketamine anesthesia: A randomized, double-blind, placebo-controlled study. J Clin Anesth. 2000;12:19–25. doi: 10.1016/s0952-8180(99)00131-2. [DOI] [PubMed] [Google Scholar]
  • 25.Nishikawa T, Kimura T, Taguchi N, Dohi S. Oral clonidine preanesthetic medication augments the pressor responses to intravenous ephedrine in awake or anesthetized patients. Anesthesiology. 1991;74:705–710. doi: 10.1097/00000542-199104000-00014. [DOI] [PubMed] [Google Scholar]

Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES